Entry
Name
Gastric cancer - Equus asinus (ass)
Description
Gastric cancer (GC) is one of the world's most common cancers. According to Lauren's histological classification gastric cancer is divided into two distinct histological groups - the intestinal and diffuse types. Several genetic changes have been identified in intestinal-type GC. The intestinal metaplasia is characterized by mutations in p53 gene, reduced expression of retinoic acid receptor beta (RAR-beta) and hTERT expression. Gastric adenomas furthermore display mutations in the APC gene, reduced p27 expression and cyclin E amplification. In addition, amplification and overexpression of c-ErbB2, reduced TGF-beta receptor type I (TGFBRI) expression and complete loss of p27 expression are commonly observed in more advanced GC. The main molecular changes observed in diffuse-type GCs include loss of E-cadherin function by mutations in CDH1 and amplification of MET and FGFR2F.
Class
Human Diseases; Cancer: specific types
BRITE hierarchy
Pathway map
Ortholog table
Organism
Equus asinus (ass) [GN:
eai ]
Gene
123277756 REG4; LOW QUALITY PROTEIN: regenerating islet-derived protein 4 [KO:K22244 ]
106834158 GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402 ]
106825069 GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402 ]
106825118 GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402 ]
106844271 LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068 ]
106834121 LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068 ]
106845228 DVL1; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-1 [KO:K02353 ]
106844176 DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353 ]
106834527 DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353 ]
123278957 FRAT2; LOW QUALITY PROTEIN: GSK-3-binding protein FRAT2 [KO:K03096 ]
106834222 APC2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085 ]
106832251 APC; LOW QUALITY PROTEIN: adenomatous polyposis coli protein [KO:K02085 ]
106829795 EGF; LOW QUALITY PROTEIN: pro-epidermal growth factor [KO:K04357 ]
106834253 SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447 ]
106841633 SHC3; LOW QUALITY PROTEIN: SHC-transforming protein 3 [KO:K17448 ]
106830292 GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
106838100 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
106829313 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
106836695 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
106840141 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649 ]
106822593 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
106824993 PIK3R2; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
106843812 TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375 ]
106836714 TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376 ]
106830938 TGFB3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377 ]
106831216 SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500 ]
106840608 SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605 ]
106844246 FGF4; LOW QUALITY PROTEIN: fibroblast growth factor 4 [KO:K04358 ]
106831440 FGF23; LOW QUALITY PROTEIN: fibroblast growth factor 23 [KO:K22428 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Tan P, Yeoh KG
Title
Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
Journal
Reference
Authors
Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C
Title
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.
Journal
Reference
Authors
Stock M, Otto F
Title
Gene deregulation in gastric cancer.
Journal
Reference
Authors
Panani AD
Title
Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Journal
Reference
Authors
Vauhkonen M, Vauhkonen H, Sipponen P
Title
Pathology and molecular biology of gastric cancer.
Journal
Reference
Authors
Smith MG, Hold GL, Tahara E, El-Omar EM.
Title
Cellular and molecular aspects of gastric cancer.
Journal
Reference
Authors
Zheng L, Wang L, Ajani J, Xie K.
Title
Molecular basis of gastric cancer development and progression.
Journal
Reference
Authors
Yuasa Y
Title
Control of gut differentiation and intestinal-type gastric carcinogenesis.
Journal
Reference
Authors
Wessler S, Krisch LM, Elmer DP, Aberger F
Title
From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.
Journal
Reference
Authors
Yan LH, Wei WY, Xie YB, Xiao Q
Title
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.
Journal
Reference
Authors
Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W, Tahara E
Title
Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.
Journal
Reference
Authors
Li X, Wu WK, Xing R, Wong SH, Liu Y, Fang X, Zhang Y, Wang M, Wang J, Li L, Zhou Y, Tang S, Peng S, Qiu K, Chen L, Chen K, Yang H, Zhang W, Chan MT, Lu Y, Sung JJ, Yu J
Title
Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.
Journal
Reference
Authors
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA
Title
Gastric cancer-molecular and clinical dimensions.
Journal
Reference
Authors
Bertotti A, Sassi F
Title
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies.
Journal
Reference
Authors
Appleman LJ
Title
MET signaling pathway: a rational target for cancer therapy.
Journal
Reference
Authors
Eder JP, Vande Woude GF, Boerner SA, LoRusso PM
Title
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.
Journal
Reference
Authors
Feng Y, Ma PC
Title
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.
Journal
Reference
Authors
Katoh M, Nakagama H
Title
FGF receptors: cancer biology and therapeutics.
Journal
Reference
Authors
Katoh M
Title
FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.
Journal
Reference
Authors
Katoh M
Title
Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics and therapeutics.
Journal
Related pathway
KO pathway
LinkDB
All DBs